David Kramer: The first US production in 30 years of molybdenum-99, the parent isotope of the most widely used medical radioisotope, is expected to begin within weeks after federal regulators approved a manufacturing process developed by Wisconsin-based NorthStar Medical Radioisotopes. NorthStar received $25 million in matching funds from DOE for development of the neutron capture process and $14.8 million of an expected $25 million total for its accelerator approach.
Latest from John Shanahan
- Venezuela oil shock and economc catastrophe (Virginia Lopez, AL JAZEERA)
- Recent Temperature and CO2 Disconnect (Thomas Wysmuller) USofA
- Scientists and engineers working for a better world (John Shanahan, Wade Allison) USofA UK
- Wind and solar details without subsidies (John Shanahan) USofA
- Von den klimazielen verabschieden (Daniel Wetzel, Die Welt) Germany German Deutsch